Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Aditxt, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 39.3K | 48.0K | +8.64K (+22.0%) |
| Value | $50.5K | $35.9K | −$14.6K (−29.0%) |
New holders (4)
Institutions that held Aditxt, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 14,350 | $10.8K | 0.00% |
| Two Sigma Securities, LLC | 10,982 | $8.26K | 0.00% |
| Citigroup Inc | 1,645 | $1.24K | 0.00% |
| TD Waterhouse Canada Inc. | 1 | $1 | 0.00% |
Sold out (3)
Institutions that held Aditxt, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| HRT Financial LP | 13,459 | $17.0K |
| Raymond James Financial Inc | 89 | $114 |
| Jones Financial Companies LLLP | 1 | $1 |